心不全POC・LOCデバイスの世界市場：動向、予測、競合分析（～2030年）

世界の心不全POC・LOCデバイスの市場規模は、2024～2030年にかけてCAGR 15.9%で成長し、2030年までに推定3億米ドルに達すると予測されています。心不全POC・LOCデバイス市場の将来は、診療所、病院、家庭、介護付き医療施設、ラボ市場での機会で有望視されています。この市場の主な促進要因は、小型化、ラボオンチップ技術がコスト効率、スループット、操作の簡便性、分析の面で疾患診断の強化に大きな可能性を示していること、および心血管疾患診断のためのラボオンチップ技術に基づく革新的なアッセイの創出に向けた研究開発の取り組みです。

心不全POC・LOCデバイス市場の洞察

Lucintelは、心血管疾患に起因する死亡率と罹患率に関する懸念の高まりにより、予測期間中マイクロ流体工学が最大セグメントであり続けると予測しています。

外来診療所では、タイムリーで正確な診断を実現し、心不全に対する十分な情報に基づく治療決定を可能にするために、ポイントオブケア機器を大規模に採用する傾向が強まっているためです。

北米は、米国市場の主要企業が世界の心不全分野の大幅な有機的収益成長に大きく貢献していることから、予測期間中も最大地域であり続けると思われます。

よくある質問

Q1.市場規模は？

A1.世界の心不全POC・LOCデバイス市場は、2030年までに推定3億米ドルに達すると予想されています。

Q2.市場の成長予測は？

A2.世界の心不全POC・LOCデバイス市場は、2024～2030年にかけてCAGR 15.9%で成長すると予測されています。

Q3.市場の成長に影響を与える主な促進要因は？

A3.この市場の主な促進要因は小型化であり、ラボオンチップ技術はコスト効率、スループット、操作の簡便性、分析の面で疾患診断の強化に大きな可能性を示し、心血管疾患診断のためのラボオンチップ技術に基づく革新的なアッセイの創出に向けた研究開発が進められています。

Q4.市場の主要セグメントは？

A4.心不全POC・LOCデバイス市場の将来は、診療所、病院、家庭、介護付きヘルスケア施設、およびラボ市場での機会により有望視されています。

Q5.市場の主要企業は？

A5.心不全POC・LOCデバイスの主要企業の一部は以下の通り。

• Abbott
• Danahar
• Siemens Healthineers
• F. Hoffmann-La Roche
• Quidel
• bioMerieux
• Trinity BiotechInstrumentation

Q6.今後、最大となる市場セグメントは？

A6.Lucintelは、心血管疾患に起因する死亡率と罹患率に関する懸念の高まりにより、マイクロ流体工学が予測期間中最大のセグメントであり続けると予測しています。

Q7.市場において、今後5年間に最大になると予想される地域は？

A7.北米は、米国市場の主要企業が世界の心不全分野の大幅な有機的収益成長に大きく貢献しているため、予測期間中も最大地域であり続けると予想されます。

Q8.レポートのカスタマイズは可能？

A8.はい、Lucintelは追加費用なしで10％のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界の心不全POC・LOCデバイス市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 市場動向と予測分析：2018～2030年

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界の心不全POC・LOCデバイス市場動向（2018～2023年）と予測（2024～2030年）
• 世界の心不全POC・LOCデバイス市場：技術別
  • マイクロ流体工学
  • アレイベースシステム
  • その他
• 世界の心不全POC・LOCデバイス市場：検査タイプ別
  • プロテオミクス検査
  • メタボローム検査
  • ゲノム検査
• 世界の心不全POC・LOCデバイス市場：最終用途産業別
  • 診療所
  • 病院
  • 家庭
  • 生活支援ヘルスケア施設
  • 研究者
  • その他

第4章 市場動向と予測分析：地域別（2018～2030年）

• 世界の心不全POC・LOCデバイス市場：地域別
• 北米
• 欧州
• アジア太平洋
• その他の地域

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • 技術別
  • 検査タイプ別
  • 最終用途産業別
  • 地域別
• 世界の心不全POC・LOCデバイス市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の心不全POC・LOCデバイス市場の生産能力拡大
  • 世界の心不全POC・LOCデバイス市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• Abbott
• Danahar
• Siemens Healthineers
• F. Hoffmann-La Roche
• Quidel
• bioMerieux
• Trinity BiotechInstrumentation

Heart Failure POC & LOC Device Trends and Forecast

The future of the heart failure POC & LOC device market looks promising with opportunities in the clinics, hospitals, homes, assisted living healthcare facilities, and laboratories markets. The heart failure POC & LOC device market is expected to reach an estimated $0.3 billion by 2030 with a CAGR of 15.9% from 2024 to 2030. The major drivers for this market are miniaturization, lab-on-chip technology shows significant potential for enhancing disease diagnosis in terms of cost-efficiency, throughput, simplicity of operation, and analysis and research and development efforts directed at creating innovative assays based on lab-on-chip technology for cardiovascular disease diagnosis.

A more than 150-page report is developed to help in your business decisions.

Heart Failure POC & LOC Device by Segment

The study includes a forecast for the global heart failure POC & LOC device by technology, test type, end use industry, and region.

Heart Failure POC & LOC Device Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

• Microfluidics
• Array-Based Systems
• Others

Heart Failure POC & LOC Device Market by Test Type [Shipment Analysis by Value from 2018 to 2030]:

• Proteomic Testing
• Metabolomic Testing
• Genomic Testing

Heart Failure POC & LOC Device Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

• Clinics
• Hospitals
• Home
• Assisted Living Healthcare Facilities
• Laborator
• Others

Heart Failure POC & LOC Device Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Heart Failure POC & LOC Device Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies heart failure POC & LOC device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the heart failure POC & LOC device companies profiled in this report include-

• Abbott
• Danahar
• Siemens Healthineers
• F. Hoffmann-La Roche
• Quidel
• bioMerieux
• Trinity BiotechInstrumentation

Heart Failure POC & LOC Device Market Insights

Lucintel forecasts that microfluidics will remain the largest segment over the forecast period due to increasing worry regarding mortality and morbidity rates stemming from cardiovascular diseases.

Within this market, clinic will remain the largest segment due to outpatient clinics are increasingly employing point-of-care devices on a larger scale to achieve timely and accurate diagnoses, enabling well-informed treatment decisions for heart failure.

North America will remain the largest region over the forecast period due to major key players in the u.s. market are significantly contributing to substantial organic revenue growth in the global heart failure sector.

Features of the Heart Failure POC & LOC Device Market

Market Size Estimates: Heart failure POC & LOC device market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Heart failure POC & LOC device market size by technology, test type, end use industry, and region in terms of value ($B).

Regional Analysis: Heart failure POC & LOC device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technology, test type, end use industry, and regions for the heart failure POC & LOC device market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the heart failure POC & LOC device market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the heart failure POC & LOC device market size?

Answer: The global heart failure POC & LOC device market is expected to reach an estimated $0.3 billion by 2030.

Q2. What is the growth forecast for heart failure POC & LOC device market?

Answer: The global heart failure POC & LOC device market is expected to grow with a CAGR of 15.9% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the heart failure POC & LOC device market?

Answer: The major drivers for this market are miniaturization, lab-on-chip technology shows significant potential for enhancing disease diagnosis in terms of cost-efficiency, throughput, simplicity of operation, and analysis and research and development efforts directed at creating innovative assays based on lab-on-chip technology for cardiovascular disease diagnosis.

Q4. What are the major segments for heart failure POC & LOC device market?

Answer: The future of the heart failure POC & LOC device market looks promising with opportunities in the clinics, hospitals, homes, assisted living healthcare facilities, and laboratories markets.

Q5. Who are the key heart failure POC & LOC device market companies?

Answer: Some of the key heart failure POC & LOC device companies are as follows.

• Abbott
• Danahar
• Siemens Healthineers
• F. Hoffmann-La Roche
• Quidel
• bioMerieux
• Trinity BiotechInstrumentation

Q6. Which heart failure POC & LOC device market segment will be the largest in future?

Answer: Lucintel forecasts that microfluidics will remain the largest segment over the forecast period due to increasing worry regarding mortality and morbidity rates stemming from cardiovascular diseases.

Q7. In heart failure POC & LOC device market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to major key players in the u.s. market are significantly contributing to substantial organic revenue growth in the global heart failure sector.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the heart failure POC & LOC device market by technology (microfluidics, array-based systems, and others), test type (proteomic testing, metabolomic testing, and genomic testing), end use industry (clinics, hospitals, home, assisted living healthcare facilities, laborator, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Heart Failure POC & LOC Device Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Heart Failure POC & LOC Device Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Heart Failure POC & LOC Device Market by Technology
  • 3.3.1: Microfluidics
  • 3.3.2: Array-Based Systems
  • 3.3.3: Others
• 3.4: Global Heart Failure POC & LOC Device Market by Test Type
  • 3.4.1: Proteomic Testing
  • 3.4.2: Metabolomic Testing
  • 3.4.3: Genomic Testing
• 3.5: Global Heart Failure POC & LOC Device Market by End Use Industry
  • 3.5.1: Clinics
  • 3.5.2: Hospitals
  • 3.5.3: Home
  • 3.5.4: Assisted Living Healthcare Facilities
  • 3.5.5: Laborator
  • 3.5.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Heart Failure POC & LOC Device Market by Region
• 4.2: North American Heart Failure POC & LOC Device Market
  • 4.2.2: North American Heart Failure POC & LOC Device Market by End Use Industry: Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laborator, and Others
• 4.3: European Heart Failure POC & LOC Device Market
  • 4.3.1: European Heart Failure POC & LOC Device Market by Technology: Microfluidics, Array-Based Systems, and Others
  • 4.3.2: European Heart Failure POC & LOC Device Market by End Use Industry: Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laborator, and Others
• 4.4: APAC Heart Failure POC & LOC Device Market
  • 4.4.1: APAC Heart Failure POC & LOC Device Market by Technology: Microfluidics, Array-Based Systems, and Others
  • 4.4.2: APAC Heart Failure POC & LOC Device Market by End Use Industry: Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laborator, and Others
• 4.5: ROW Heart Failure POC & LOC Device Market
  • 4.5.1: ROW Heart Failure POC & LOC Device Market by Technology: Microfluidics, Array-Based Systems, and Others
  • 4.5.2: ROW Heart Failure POC & LOC Device Market by End Use Industry: Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laborator, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Heart Failure POC & LOC Device Market by Technology
  • 6.1.2: Growth Opportunities for the Global Heart Failure POC & LOC Device Market by Test Type
  • 6.1.3: Growth Opportunities for the Global Heart Failure POC & LOC Device Market by End Use Industry
  • 6.1.4: Growth Opportunities for the Global Heart Failure POC & LOC Device Market by Region
• 6.2: Emerging Trends in the Global Heart Failure POC & LOC Device Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Heart Failure POC & LOC Device Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Heart Failure POC & LOC Device Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abbott
• 7.2: Danahar
• 7.3: Siemens Healthineers
• 7.4: F. Hoffmann-La Roche
• 7.5: Quidel
• 7.6: bioMerieux
• 7.7: Trinity BiotechInstrumentation